Zephyr AI is a healthcare technology company that strives to develop new precision medicine treatments in oncology and cardiometabolic disease. Zephyr AI was founded in 2020 and is headquartered in Fairfax, VA. The company uses its platform’s AI capabilities and data analytics to look at vast amounts of healthcare information. With this, the company aims to serve patients through tailored treatment plans, potential new drug discoveries, repositioning existing drugs for new use cases, and clinical decision support that seeks to enable doctors to make informed decisions.
Zephyr AI is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Zephyr AI pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Zephyr AI is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.